AACCE Investments
ScreenerStocksIndicesPicksETFsBlogPricing

© 2026 ACCE Investments. All rights reserved.

ACCE Investments - Institutional-grade stock research for retail investors | BetaList
IndicesStocksETFsScreenerBlogGlossaryCompareMarket dataAdvisors
TermsPrivacyCookiesDisclaimerLegal noticeProfessional termsAboutContact
STRA

Strategic Education Inc. Common Stock (STRA) fair value

Consumer Defensive · Education & Training Services · NASDAQ · United States
$81.74+0.18%
Market cap $1.8BNext earnings 2026-11-05Updated Oct 21, 2026
Add earnings to calendarGoogle
Our verdict
Trades 22% below our fair value
Price
$81.74
Model fair valueConfidence: good
$105
Model range
$85.49 to $133
Fair value $105
Price $81.74
5 models fit Strategic Education Inc. Common Stock and they partly agree: 3 of 5 land within 15% of the average. The price is below every model.
Two or more of our models back this value.
Discount(i)Gold84
Valued as a mature, profitable company: Discounted cash flow, P/E comparison, EV/EBITDA comparison, Graham number, and Dividend discount.
ACCE opinionStrategic Education Inc. Common Stock (STRA)
Fair value (5 models)
$105
ACCE price target
$97.00
Rating
Undervalued
Horizon
12 months
Fair value published on 21 Oct 2026, 11:06 CEST; previously $133 since 16 Oct 2026, 00:00 CEST.
ACCE price target published on 11 Oct 2026, 00:00 CEST.
Rating published on 21 Oct 2026, 11:06 CEST.
Price used: $81.74 at the close on 23 Oct 2026, 22:00 CEST.
Models: Discounted cash flow, P/E comparison, EV/EBITDA comparison, Graham number, and Dividend discount.
Fair value: the average of the applicable valuation models (discounted cash flow, multiples, residual income, dividend discount, shareholder yield), each run on the latest financial statements and the market price shown. Opinion columns (fair value, target, rating) are shown apart from the data. Full methodology: acceinvestments.com/data/how-we-value-stocks
Full methodology
Conflicts of interest: The author holds no personal position in this security. General statement
Produced by ACCE Investments (acceinvestments.com)
Data
Price vs fair value
21.9% below
+28.0% to fair value
ACCE score
71
out of 100
Analysts
67% buy
3 covering
P/E
13.6x
forward 9.7x
1-year return
-2.3%
Dividend yield
2.94%

Strategic Education Inc. Common Stock in four questions

Plain answers, details below
Free accounts get 5 full stock pages a month, including the four answers.
OverviewAsk ACCEValuationQualityAnalystsSmart MoneyCompareNews and Record

Overview

ACCE thesis

Strategic Education operates a portfolio of postsecondary institutions, including Strayer University and Capella University, that serves mostly adult learners through online and hybrid degree programs. The business earns a 49.1% gross margin and a 15.7% operating margin, which is solid for a for-profit education provider that depends on enrollment and regulatory eligibility rather than a proprietary product. Revenue growth of 4.9% is modest, but the stock trades at 13.6 times trailing earnings and 9.3 times forward earnings, a gap that implies the market expects earnings to rise faster than sales. The stock is outside the major indices, which likely keeps coverage thin and leaves room for mispricing. The case for a deeper look rests on whether that forward discount holds up once enrollment trends and federal aid policy are checked against the margin profile.

AI-assisted·How I use AIWritten Oct 18, 2026
⚠ Investor warnings · 2 flagsAI-assisted·How I use AI
  • moderate
    Revenue growth slowing
    Revenue grew 4.9% year on year against a 4.3% five-year CAGR, while QoQ revenue fell 5.3%. Top-line momentum has softened recently.
  • moderate
    Elevated short interest
    Short interest stands at 9.4% of shares, a meaningful bet against the stock that could amplify volatility around earnings.

AI research notes

AI-assisted·How I use AIWritten Oct 18, 2026 · figures from 2026-06-30 · prices to Oct 23, 2026
Why it could do well
  • Free cash flow of $154M over the last twelve months gives an 8.5% free cash flow yield at today's price.
  • Debt is light at 0.07 times equity, and the diluted share count fell 5.5% last fiscal year, returning value to owners.
Why it could disappoint
  • Revenue grew only 4.9% year over year, so the earnings growth leans on margin gains that are harder to repeat for years.
  • Return on invested capital of 5.9% is thin, so the business earns little more than its cost of capital on new money.
  • Last quarter's earnings per share missed expectations, coming in at 1.76 against 1.79 expected, a 1.7% shortfall.
Each chip shows the exact figure and where it comes from. A claim without a source is not published.

Next results

Nov 5, 2026
We update the fair value about 2 days after the results, once the new figures are filed.Add to calendarGoogle

Walk me through this stock

Plain-English pros, cons, and what to watch. Pro feature.

PRO

Ask ACCE

Valuation

INVESTOR
Where STRA's valuation models land
Price
$81.74
Model fair value
$105
Model range
$85.49 to $133
Fair value $105
Price $81.74
The price is below the whole model range.
Model
Fair value
Upside
Discounted cash flow
Dividend discount
EV/EBITDA comparison
Graham number
P/E comparison
Create a free account: 5 full stock pages a month, no card.

See what each model says, the assumptions behind it, the bad, normal and good cases, and why the fair value changed.

Quality

INVESTOR
Quality and conviction INVESTOR FEATURE

The full quality picture: a reason under every score, how the scores moved, and the conviction breakdown.

  • +A plain reason under every score
  • +Conviction breakdown and growth / value / quality / momentum scores
  • +Score history: how each score moved over time

Analysts

Wall Street consensus

Bullish67% buy · 3 covering analysts
● Strong buy 1● Buy 1● Hold 1● Sell 0● Strong sell 0
Analyst intelligence INVESTOR FEATURE

The full analyst picture: the price-target distribution against the current price, forward consensus estimates, and how ACCE's own models compare.

  • +Price-target low / average / high vs the current price, with implied upside
  • +Forward revenue and EPS consensus by fiscal year
  • +ACCE fair-value models lined up against the Street

Smart Money

PRO

In one line

Trades are only made public after a delay. We show the delay so you know how old the news is.

Company insiders
No trades filed
Last 90 days
Congress
No trades filed
Last 180 days
Average delay
No trades filed
From trade to public filing
Do politicians beat the market? Our backtest →
Smart money tracking PRO FEATURE

Follow the informed money: 13F position changes, insider and Congress trades, and 13D activist filings.

  • +Quarter-over-quarter institutional position changes
  • +Every insider and Congress trade, with how late it was disclosed
  • +Active 13D activist filings and top holders

Compare

Where it sits vs peers

News and Record

Press releases mentioning this company

Recent performance

1 week
+0.5%
1 month
+4.5%
3 months
+8.1%
6 months
+11.2%
YTD
+1.9%
1 year
-2.3%

SEC filings

Recommendation history, last 12 months

DateTypeNewPreviousPrice
21 Oct 2026, 11:06 CESTRatingUndervaluedfirst publication$80.80
21 Oct 2026, 11:06 CESTFair value$105$133$80.80
16 Oct 2026, 00:00 CESTFair value$133$137$80.97
11 Oct 2026, 00:00 CESTACCE price target$97.00first publication$82.39
11 Oct 2026, 00:00 CESTFair value$137$119$82.39
5 Oct 2026, 00:00 CESTFair value$119$117$79.72
28 Sept 2026, 00:00 CESTFair value$117$121$76.83
15 Sept 2026, 00:00 CESTFair value$121$124$81.66
7 Sept 2026, 00:00 CESTFair value$124$126$81.59
22 Aug 2026, 00:00 CESTFair value$126$124$82.25

This analysis is not personalised investment advice and does not take your situation, objectives or risk tolerance into account. ACCE Investments is not an authorised investment firm.

Investing in shares carries a risk of losing capital. The value of an investment can go down as well as up.

Valuation horizon: 12 months from the publication date.

Conflicts of interest. ACCE Investments is operated by Adrien Chantreuil, who may hold personal positions in the securities analysed. Positions are declared on each security. ACCE receives no payment from the companies analysed or from any intermediary for this analysis.

Get the full STRA page, free

Every model, the scenarios, fair value history, AI notes and the four questions. 5 full stock pages every month on the free plan, no card.

Free accounts get 5 full stock pages a month, including the full page.

Snapshot

Growth56Value92Quality71Momentum63Total71
Valuation
Trailing P/E
13.6x
Forward P/E
9.7x
PEG
0.55
P/B
1.04x
EV / Revenue
1.3x
Book value/sh
$74.38
Enterprise value
$1.7B
Profitability
ROE
8.2%
FCF yield
8.50%
ROIC
5.9%
Health and risk
Debt / equity
0.07
Dividend yield
2.94%
Beta
0.47

Price

-2.7% · 1Y

Ask anything about STRA

Answered from Strategic Education Inc. Common Stock fundamentals + recent valuations. Every number shows its source and date.

This stock Peer Peer median weaker → stronger
P/Ebetter than 50% of peers
low 0.0x13.6xhigh 100.1x
ROEbetter than 33% of peers
low -15%8%high 18%
Div yieldbetter than 83% of peers
low 0.0%2.9%high 4.4%

Peers

Prices Oct 23, 2026
CompanyPriceFair valuevs fair valueP/EROEQualityScore
STRA Strategic Education Inc. Common Stock$81.74$10522% below13.6x8.2%7171
PRDO Perdoceo Education Corporation Common Stock$33.82$4220% below11.9x17.5%9072
COUR Coursera Inc. Common Stock$5.07$1566% below--15.2%4345
DAO Youdao Inc. American Depositary Shares each representing one Class A Ordinary Share$19.35--100.1x0.0%3748
AFYA Afya Limited Class A Common Shares$14.91$3253% below9.1x16.7%8675
UTI Universal Technical Institute Inc Common Stock$21.66$1823% above35.8x10.5%4637
MH McGraw Hill Inc. Common Stock$14.80$2028% below30.8x17.3%5971

Sector report card

Where STRA ranks against its sector peers on each metric.

Computing percentiles…
  • Business Wire•Sep 30, 2026
    Strategic Education, Inc. Schedules Third Quarter 2026 Results Conference Call
  • Business Wire•Sep 16, 2026
    Harris Poll: 70% of Gen Z Healthcare Workers Look to Leave as U.S. Faces Critical Healthcare Workforce Shortage, Commissioned by Workforce Edge
  • Business Wire•Aug 20, 2026
    Capella University Announces Appointment of Oncology Leader Dr. Saro Sarkisian to Board of Trustees
4 more press releases · full archive on Investor+.INVESTOR
32 filings of 33
July 2026
Jul 29
8-KCurrent reportPeriod 2026-07-29
View on SEC →
Jul 29
10-QQuarterly reportPeriod 2026-06-30
View on SEC →
June 2026
Jun 5
Form 4Insider transactionPeriod 2026-06-04
View on SEC →
29 more filings + AI summaries on Investor+.INVESTOR